WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
157 hedge funds and large institutions have $2B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 42 reducing their positions, and 19 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 42
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
2% more funds holding
Funds holding: 154 → 157 (+3)
5% more capital invested
Capital invested by funds: $1.91B → $2B (+$90M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
45% less call options, than puts
Call options by funds: $1.31M | Put options by funds: $2.36M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$55.5M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$31.8M |
| 3 |
Bank of New York Mellon
New York
|
+$27.1M |
| 4 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$9M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$8.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$63.6M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$37.6M |
| 3 |
JP Morgan Chase
New York
|
-$27.5M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$26.6M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$25.2M |
WX Hedge Fund Activity: Q3 2014 in Review
157 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2014, worth a combined $2B — up 4.7% from $1.91B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new WX positions and 19 closed out — a net gain of 3 holders — while 65 added to existing stakes and 42 trimmed.
The largest buyer was Fidelity International, adding an estimated $55.5M. The largest seller was Mirae Asset Global Investments, cutting an estimated $63.6M.
- 157 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2014, up from 154 in Q2 2014.
- Funds reported $2B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2014, up 4.7% quarter-over-quarter.
- 22 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2014 and 19 closed out, a net change of +3 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2014 was Fidelity International, an estimated $55.5M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2014 was Mirae Asset Global Investments, an estimated $63.6M sold.
Based on aggregated 13F filings for Q3 2014.